A
Acuitas Therapeutics
Vancouver, Canada
Founded 2009
About
Leading developer of lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics, partner for COVID-19 vaccines
Company Details
- Type
- commercial
- Employees
- 100-200
- Funding
- Private
Key Products
- LNP Delivery Platform